ENDRA Life Sciences NDRA
NASDAQ NDRA
$5.50 +0.40 (+7.84%)
At close: Sep 18, 2026 · 4:00 PM EDT

ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016)

ENDRA Life Sciences' (NDRA) quarterly Amortization of Deferred Charges came in at $338164.0 in Q4 2016, down 2.3% quarter-over-quarter from $346119.0 in Q3 2016.

Analysis

ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Amortization of Deferred Charges for 1 consecutive years, with $338164.0 the latest figure, recorded in Q4 2016.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $338164.0 in Q4 2016; TTM through Dec 2017 was $684283.0, a N/A change from a year earlier, with the FY2020 full-year figure at $232426.0, down 90.13% from the prior year.
  • Amortization of Deferred Charges was $338164.0 for Q4 2016 at ENDRA Life Sciences, down from $346119.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $346119.0 in Q3 2016 and troughed at $338164.0 in Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 28.97 Bn 27.09 Bn 2.18 Bn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn
3 Heartflow 4.40 Bn 4.03 Bn 53.19 Mn
4 Neogen 2.83 Bn 2.64 Bn 107.80 Mn
5 Butterfly Network 1.88 Bn 1.75 Bn 23.29 Mn
6 Ceribell 931.50 Mn 802.24 Mn 25.94 Mn
7 Varex Imaging 779.32 Mn 694.02 Mn 76.70 Mn
8 Anbio Biotechnology 755.43 Mn 743.53 Mn -
9 QuidelOrtho 725.35 Mn 601.95 Mn -
10 ENDRA Life Sciences 8.25 Mn 2.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 338,164.00
Sep 30, 2016 346,119.00